Lisa Rowley

Lisa Rowley

Auto-generated profile, based on publicly available information

Lisa Rowley

Department of Nuclear Medicine University Hospitals, Coventry and Warwickshire NHS Trust Coventry UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in Journal of 3D Printing in Medicine
Verified
Journal Article
Open access
LRLisa M Rowley
Lisa M Rowley
EDElizabeth M Davies
Elizabeth M Davies
ECEmma Chung
Emma Chung
Aim: Assessment of the imaging properties of 3D-printable materials using dual energy computed tomography (DECT) to match clinical values for imaging phantoms. Methods: 3D-printed samples were imag... Plain language summary To investigate how different 3D-printed materials respond when they are scanned using a specialist computed tomography (CT) imaging system called dual energy CT. The response...

27 June 2026 in EJNMMI Physics
Verified
Journal Article
Open access
LRL. M. Rowley
L. M. Rowley
CPC. Pickles
C. Pickles
KHK. Hodgson
K. Hodgson
SKS. E. Kallioinen
S. E. Kallioinen
DMD. MacDonald
D. MacDonald
OAO. Adesanya
O. Adesanya
To evaluate the radiation protection requirements for a UK first specimen PET-CT scanner, the AURA10 (Xeos, Ghent), as assessed through a clinical trial investigating its use for intra-operative surgical margin assessment in urology and head and neck (H&N) tumour removal. A radiation risk assessment was performed to inform radiation protection requirements and training. 0.8 MBq/kg of 18Fluorine fluorodeoxyglucose and 50 MBq of 68Gallium prostate-specific membrane antigen were administered for H&N and urology cases respectively. Whole body optically stimulated luminescence dosimeters, finger and eye ThermoLuminescent dosimeters and electronic personal dosimeters were issued to staff in theatres, recovery, and histopathology. Dose rate measurements were recorded at the position of staff members in theatres. Measured counts and dose rate from the resected specimen and swabs were obtained and contamination monitoring of the room were performed following removal of the patient. Training sessions and dry runs with surgical staff helped identify radiation risks and optimise workflow. Occupational doses from surgeons and scrub nurses were the highest for both modalities. Doses to other theatre staff were below dose limits for members of the public in the UK. Doses to staff outside theatres, including recovery and histopathology, were found to be below threshold values. Low level contamination was present in swabs (< 6 kBq and < 250 kBq for H&N and urology cases respectively). Thorough staff training, systems of work and shielding are required to ensure radiation doses to staff are minimised and contamination and radioactive waste are contained. There were difficult occasions during shift changes and untrained staff rota-ed in, but nuclear medicine supervision and then the introduction of theatre-based cascade trainers helped solidify learning and provide assurance to theatre staff and staff showed good compliance with the systems of work in place. Annual doses to theatre staff are heavily dependent on workload, with surgeons and scrub nurses closest to the patient receiving whole body doses of 39 µSv and 12 µSv, and finger doses of 88 µSv and 48 µSv respectively per case for H&N. Corresponding urology doses per case were measured as 7.2 µSv and 2.5 µSv for whole body and 16 µSv and below threshold values for the assisting surgeon and scrub nurse respectively. www. gov. URL trail registry record: Study Details | NCT06676943 | Investigating the Diagnostic Performance of High-resolution Specimen PET-CT in Determining Margin Status in Cancer Resection | ClinicalTrials.gov.

18 September 2026 in Head & Neck
Verified
Journal Article
Closed access
GWGary M. Walton
Gary M. Walton
OAOludolapo Adesanya
Oludolapo Adesanya
LRLisa Rowley
Lisa Rowley
SKSusanna E. Kallioinen
Susanna E. Kallioinen
ATAlica Torres‐Rendon
Alica Torres‐Rendon
PNPrady Naredla
Prady Naredla